The World Health Organization reaffirms the critical need for research and development (R&D) of new antibiotics to tackle the threat of drug-resistant tuberculosis (TB). Addressing drug-resistant TB research is a top priority for WHO and for the world, said Dr Margaret Chan, WHO Director-General. More than US$ 800 million per year is currently necessary to fund badly needed research into new antibiotics to treat TB.
New data published by the World Health Organization (WHO) in its 2016 Global Tuberculosis (TB) Report show that countries need to move much faster to prevent, detect and treat the disease if they are to meet global targets. Governments have agreed on targets to end the TB epidemic both at the World Health Assembly and at the United Nations General Assembly within the context of the Sustainable Development Goals.
Tuberculosis should be treated as a disease of poverty and inequality, the World Medical Association said on Wednesday. Against the background of the global growth of tuberculosis, the WMA is updating its training course for physicians to emphasize the relationship between poverty and TB.
The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization’s Global Tuberculosis Report 2015, which was released on Wednesday in Washington, DC.
The long-held idea that Europeans were the first to bring tuberculosis to the Americas when they arrived in the 15th Century has been thrown into doubt. Instead, a study suggests that the deadly disease was present in the area hundreds of years before Christopher Columbus made landfall.
Tuberculosis cases in Buenos Aires City have increased 25% between 1985 and 2011 according to a paper presented by a Federal Attorney who links the surge to dreadful working conditions in many of the sweat-shops in the Argentine capital that employ cheap foreign labor.
The World Health Organization and the Global Fund to Fight AIDS, TB and Malaria said on Monday that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at least 1.6 billion dollars in international funding for treatment and prevention of the disease.
Peru has 37% of all multi-resistant tuberculosis cases in the Americas and one in four patients of the disease abandon medication in a mild stage of the disease according to the World Health Organization.